Product NDC: | 54859-702 |
Proprietary Name: | Conex |
Non Proprietary Name: | Dexbrompheniramine Maleate, Pseudoephedrine HCl |
Active Ingredient(s): | 2; 60 mg/1; mg/1 & nbsp; Dexbrompheniramine Maleate, Pseudoephedrine HCl |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54859-702 |
Labeler Name: | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20071101 |
Package NDC: | 54859-702-60 |
Package Description: | 60 TABLET in 1 BOTTLE (54859-702-60) |
NDC Code | 54859-702-60 |
Proprietary Name | Conex |
Package Description | 60 TABLET in 1 BOTTLE (54859-702-60) |
Product NDC | 54859-702 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Dexbrompheniramine Maleate, Pseudoephedrine HCl |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20071101 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION |
Substance Name | DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE |
Strength Number | 2; 60 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |